The BAG5 Knockout NCI-H1703 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population featuring targeted disruption of the BAG5 gene in the human NCI-H1703 lung squamous cell carcinoma line. This heterogeneous knockout pool provides a robust loss-of-function model for investigating BAG5-dependent processes without the influence of clonal selection artifacts. The polyclonal format is particularly advantageous for interrogating protein quality control, apoptosis, and autophagy pathways in a non-small cell lung cancer (NSCLC) context, as it better reflects population-level responses.
The parental NCI-H1703 cell line was established from a primary squamous cell carcinoma of the lung and serves as a well-characterized in vitro model of NSCLC. These cells exhibit epithelial morphology and harbor genomic alterations typical of lung squamous cell carcinoma, making them a relevant platform for examining oncogenic signaling and therapeutic vulnerabilities. The NCI-H1703 background is especially suited for dissecting the interplay between chaperone networks and tumor cell survival mechanisms, given its origin from a clinically recalcitrant lung cancer subtype.
BAG5 encodes a co-chaperone that negatively regulates Hsp70/Hsc70 chaperone activity by modulating their ATPase cycles, a function central to protein folding quality control and cellular stress adaptation. The gene is transcriptionally regulated by heat shock factor 1 (HSF1) and is responsive to diverse stress stimuli. BAG5 directly interacts with Hsp70/Hsc70, forming complexes that influence the stability and activity of key downstream effectors, including parkin and caspase-3. Through these interactions, BAG5 serves as a critical node linking chaperone-mediated proteostasis to apoptotic signaling and autophagy. The BAG5-Hsp70 complex participates in the parkin-DJ-1 pathway, which is important for mitochondrial quality control and has been implicated in both NSCLC and neurodegenerative diseases.
In the context of NCI-H1703 cells, BAG5 knockout is predicted to disrupt protein quality control, potentially leading to proteotoxic stress and altered cellular homeostasis. Loss of BAG5-mediated negative regulation of Hsp70/Hsc70 may enhance apoptotic priming via derepression of caspase-3 activation and may dysregulate autophagy by influencing parkin-dependent mitophagy. These changes can impact NSCLC cell survival, proliferation, and response to chemotherapeutic agents, making this knockout model a powerful tool for dissecting co-chaperone-dependent mechanisms in lung squamous cell carcinoma.
This polyclonal BAG5 knockout cell population is eminently suitable for a wide range of research applications, including mechanistic investigations into protein quality control defects in lung cancer, functional interrogation of BAG5 in apoptotic and autophagic pathways, and preclinical validation of BAG5 as a potential drug target or biomarker. Researchers can employ a variety of representative assays to characterize the model, such as western blotting and RT-qPCR for expression analysis, immunofluorescence for localization studies, apoptosis assays (e.g., caspase-3 activity), autophagy flux assays (e.g., LC3 turnover), and cell viability assays under pharmacological or genetic perturbations. For additional technical information or to inquire about lot-specific performance, please contact Ascent Research.
